Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann.
作者信息
Gautret Philippe, Hoang Van Thuan, Colson Philippe, Raoult Didier
机构信息
IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France.
IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France; Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam.
出版信息
Int J Antimicrob Agents. 2021 Mar;57(3):106306. doi: 10.1016/j.ijantimicag.2021.106306. Epub 2021 Feb 14.
Abstract
摘要
相似文献
1
Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann.羟氯喹和阿奇霉素对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒清除的影响：对埃尔韦·塞利格曼的回应
Int J Antimicrob Agents. 2021 Mar;57(3):106306. doi: 10.1016/j.ijantimicag.2021.106306. Epub 2021 Feb 14.
2
Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors' response.羟氯喹啉联合或不联合阿奇霉素对COVID-19患者死亡率的影响：作者回应
Clin Microbiol Infect. 2021 Jan;27(1):138-140. doi: 10.1016/j.cmi.2020.10.002. Epub 2020 Oct 17.
3
Has the door closed on hydroxychloroquine for SARS-COV-2?羟氯喹啉治疗新冠病毒（SARS-CoV-2）的大门是否已关闭？
Clin Microbiol Infect. 2021 Jan;27(1):3-5. doi: 10.1016/j.cmi.2020.10.011. Epub 2020 Oct 20.
4
Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia.羟氯喹、阿奇霉素和环索奈德三联疗法治疗 COVID-19 肺炎。
J Microbiol Immunol Infect. 2021 Feb;54(1):109-112. doi: 10.1016/j.jmii.2020.09.003. Epub 2020 Oct 5.
5
Balanced evaluation of preliminary data on a candidate COVID-19 hydroxychloroquine treatment.对新冠病毒（COVID-19）羟氯喹治疗候选药物的初步数据进行平衡评估。
Int J Antimicrob Agents. 2021 Mar;57(3):106292. doi: 10.1016/j.ijantimicag.2021.106292.
6
Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.羟氯喹和阿奇霉素对新型冠状病毒肺炎患者严重急性呼吸综合征冠状病毒2清除率的影响：一项荟萃分析
Int J Antimicrob Agents. 2021 Jan;57(1):106240. doi: 10.1016/j.ijantimicag.2020.106240.
7
Hydroxychloroquine (HCQ): real treatment or false hope?羟氯喹（HCQ）：是切实有效的治疗方法还是虚幻的希望？
Int J Antimicrob Agents. 2021 Jan;57(1):106170. doi: 10.1016/j.ijantimicag.2020.106170.
8
Uncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load.羟氯喹和阿奇霉素对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒载量的影响尚不确定。
Int J Antimicrob Agents. 2021 Jan;57(1):106169. doi: 10.1016/j.ijantimicag.2020.106169.
9
Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19.羟氯喹啉和阿奇霉素治疗新型冠状病毒肺炎的临床疗效及安全性概况
Int J Antimicrob Agents. 2021 Jan;57(1):106242. doi: 10.1016/j.ijantimicag.2020.106242.
10
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited.羟氯喹和阿奇霉素用于治疗新型冠状病毒肺炎：重新审视一项开放标签非随机临床试验的结果
Int J Antimicrob Agents. 2021 Jan;57(1):106243. doi: 10.1016/j.ijantimicag.2020.106243.
引用本文的文献
1
mRNA COVID-19 Vaccines-Facts and Hypotheses on Fragmentation and Encapsulation.mRNA新冠疫苗——关于片段化和封装的事实与假说
Vaccines (Basel). 2022 Dec 24;11(1):40. doi: 10.3390/vaccines11010040.
本文引用的文献
1
Balanced evaluation of preliminary data on a candidate COVID-19 hydroxychloroquine treatment.对新冠病毒（COVID-19）羟氯喹治疗候选药物的初步数据进行平衡评估。
Int J Antimicrob Agents. 2021 Mar;57(3):106292. doi: 10.1016/j.ijantimicag.2021.106292.
2
Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes.羟氯喹和阿奇霉素治疗COVID-19的效果：一项开放标签非随机临床试验的结果，意向性分析及临床结局的更新
Int J Antimicrob Agents. 2021 Jan;57(1):106239. doi: 10.1016/j.ijantimicag.2020.106239.
3
Response to advances statistical methods and designs for clinical trials for COVID-19.对COVID-19临床试验先进统计方法和设计的回应。
Int J Antimicrob Agents. 2021 Jan;57(1):106235. doi: 10.1016/j.ijantimicag.2020.106235.
4
Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial.羟氯喹对新型冠状病毒肺炎疗效评估的回应：一项开放标签非随机临床试验的二次分析
Int J Antimicrob Agents. 2021 Jan;57(1):106237. doi: 10.1016/j.ijantimicag.2020.106237.
5
Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.羟氯喹和阿奇霉素对新型冠状病毒肺炎患者严重急性呼吸综合征冠状病毒2清除率的影响：一项荟萃分析
Int J Antimicrob Agents. 2021 Jan;57(1):106240. doi: 10.1016/j.ijantimicag.2020.106240.
6
Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load.羟氯喹啉和阿奇霉素对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒载量的不确定影响的反应。
Int J Antimicrob Agents. 2021 Jan;57(1):106244. doi: 10.1016/j.ijantimicag.2020.106244.
7
Commentary on "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial" by Gautret et al.对 Gautret 等人所著《羟氯喹啉和阿奇霉素治疗 COVID-19：一项开放标签非随机临床试验的结果》的评论
J Mark Access Health Policy. 2020 May 13;8(1):1758390. doi: 10.1080/20016689.2020.1758390. eCollection 2020.
8
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19：一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
Zotero 插件